Radioligand therapy, a targeted form of cancer treatment, is only viable for a few days after it’s manufactured. One pharmaceutical company is racing against the clock to deliver it to patients in time.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
